Tang-Du Hospital clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 166 studies whose lead sponsor is Tang-Du Hospital. 77 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Keep track of what changes. Save the Tang-Du Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 134
Focus areas
Conditions Tang-Du Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 166. Browse all 166 →
- Multi-Field-Strength MRI Brain Atlas Construction in Healthy Chinese PopulationRecruitingNCT07786233Not applicable
- A Prospective, Single-center, Phase II Study of Neoadjuvant Serplulimab Plus XELOX and Bevacizumab in Locally Advanced Rectal CancerNot yet recruitingNCT07854964Not applicable
- Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic CancerNot yet recruitingNCT07773363Phase 2
- Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal CarcinomaNot yet recruitingNCT07752394Phase 2
- Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy(PRECAL)Enrolling by invitationNCT07721441
- Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07709767Phase 2
- A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UCNot yet recruitingNCT07705126
- Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory TrialNot yet recruitingNCT07699770Phase 4
- The Effects of Coenzyme Q10 Pretreatment on Ovarian Function and Assisted Reproductive Outcomes in Patients With Ovarian Hyporesponsiveness.Not yet recruitingNCT07260773Not applicable
- Bristol Stool Scale-Based Care Pathway for Enteral Nutrition-Associated Diarrhea in Critically Ill PatientsNot yet recruitingNCT07683364Not applicable
- Safety and Efficacy Analysis of Stent-assisted Coil Embolization in the Treatment of Acute Ruptured Intracranial Aneurysms in the Perioperative Period.RecruitingNCT07683377Not applicable
- Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07678580Phase 2
- Anxiety and Depression in IBS: A Brain-Gut Axis StudyRecruitingNCT07646834
- Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast CancerNot yet recruitingNCT07618923Phase 2
- Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric CancerRecruitingNCT06128252Not applicable
- Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCCNot yet recruitingNCT07618910Phase 2
- Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar DefectsRecruitingNCT07610668
- Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCCRecruitingNCT07452601Phase 2
- Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%RecruitingNCT07596121Phase 2
- Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.RecruitingNCT07092423Not applicable
- Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal CarcinomaNot yet recruitingNCT07538206Phase 1/2
- Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung CancerNot yet recruitingNCT07538193Not applicable
- An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICHNot yet recruitingNCT07528235Phase 1
- Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/ContusionsRecruitingNCT06065046Phase 2
- Intra-arterial Methylprednisolone After Endovascular ThrombectomyRecruitingNCT07516522Phase 2
- Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)RecruitingNCT07354061Phase 1/2
- Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in InfertilityRecruitingNCT07494877
- Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled TrialRecruitingNCT07498374Not applicable
- Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCTNot yet recruitingNCT07327736Not applicable
- A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCCRecruitingNCT07385001Phase 1/2
- Ofatumumab in AQP4-IgG Seropositive NMOSDRecruitingNCT05504694Phase 1/2
- TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world StudyRecruitingNCT04182984
- Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06952621Phase 3
- Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)RecruitingNCT07377305Not applicable
- Efficacy of a Non-Invasive Endometrial Receptivity Prediction Model Based on Peripheral Blood miRNA Signatures During the Peri-Implantation Period in Improving IVF Outcomes in Patients With Unexplained RIFNot yet recruitingNCT07363018Not applicable
- Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar CancerRecruitingNCT07353723Phase 2
- Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance TherapyRecruitingNCT07141264Phase 2
- Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel OcclusionRecruitingNCT07141303Phase 3
- Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction CarcinomaNot yet recruitingNCT07092449Not applicable
- Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLCRecruitingNCT06864624Phase 2
- A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)Not yet recruitingNCT07062185Not applicable
- This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung CancerNot yet recruitingNCT06978153Phase 2
- Clinical Trial on the Efficacy and Safety of Biodegradable 3D-Printed Implants in Chest Wall Reconstruction SurgeryNot yet recruitingNCT06977022Not applicable
- Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia GravisRecruitingNCT05067348Phase 2
- Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical StudyRecruitingNCT06896747Phase 1/2
- This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete ResponseNot yet recruitingNCT06851169Phase 2
- Partial Pressure of Oxygen Control Method in Identification of Intersegmental PlaneRecruitingNCT06644066Not applicable
- Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles StudyRecruitingNCT06663059Phase 2
- A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLCNot yet recruitingNCT06503042
- Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized TrialRecruitingNCT06485544Phase 2